NM_001267550.2:c.30754+1G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001267550.2(TTN):c.30754+1G>A variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001267550.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.30754+1G>A | splice_donor_variant, intron_variant | Intron 112 of 362 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.30754+1G>A | splice_donor_variant, intron_variant | Intron 112 of 362 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1392652Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 686480
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
TTN-related disorder Pathogenic:1
The TTN c.30754+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is located in the TTN protein I-band region. RNAseq studies from heart tissue indicate this exon is not commonly included in TTN mRNA transcripts (PSI of 80-91%); however, this analysis in muscle tissue was not performed (Roberts et al. 2015. PMID: 25589632; https://www.cardiodb.org/titin/titin_exon.php?id=129). TTN truncating variants in the heterozygous state are reported in 1-2% of presumably healthy individuals and occur more frequently in exons with low PSI values, indicating this variant is more likely to be a risk variant for TTN-related cardiac disorders (Roberts et al. 2015. PMID: 25589632; Herman et al. 2012. PMID: 22335739). However, many cases of recessive congenital titinopathies in which the individual is compound heterozygous for two loss of function variants in TTN have also been reported (Ceyhan-Birsoy et al. 2013. PMID: 23975875; Chauveau et al. 2014. PMID: 24105469; Evilä et al. 2016. PMID: 27796757; Ge et al. 2019. PubMed ID: 31053406; Bryen et al. 2020. PubMed ID: 31660661). Variants that disrupt the consensus splice donor site in TTN are expected to be pathogenic for TTN-related disorders. Of note, other splicing variants in nearby exons have been reported in individuals with dilated cardiomyopathy (Roberts et al. 2015. PubMed ID: 25589632). Taken together, this variant is interpreted as likely pathogenic for TTN-related disorders. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.